Pricing Log in Create free account
Friday 6 November 2026 Export PBH’s income statement to Excel — free account

Prestige Consumer Healthcare Inc.

PBH Healthcare Drug Manufacturers Specialty & Generic

Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.

Revenue
+22.7%
EPS
−38.4%
Free cash flow
−38.2%
Total debt
+100.9%

Quarter to September 2026, against a year earlier

44.63 8.65 −16.23%
Market cap
$2.1B
P/E
13.7×
Fwd P/E
11.7×
Dividend yield
—
F-score
5/9
Altman Z
2.48
Beneish M
−2.53
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Prestige Consumer Healthcare Inc. (PBH) Debt to equity

Alert me on Debt to equity

Prestige Consumer Healthcare Inc.'s debt to equity at the end of the quarter to 30 September 2026 was 0.0×, down 0.5× from fiscal 2026 (0.5×). Over the past ten years it has ranged from 0.5× (fiscal 2026) to 2.7× (fiscal 2017) — the current reading is the lowest in ten years. That is below the Drug Manufacturers Specialty & Generic industry median of 0.0× and in line with the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2026 0.5× (2.90%)
FY2025 0.6× (18.84%)
FY2024 0.7× (26.94%)
FY2023 0.9× (0.82%)
FY2022 0.9× (14.21%)
FY2021 1.1× (26.13%)
FY2020 1.5× (9.73%)
FY2019 1.6× (2.93%)
FY2018 1.7× (36.60%)
FY2017 2.7× 22.14%

Quarterly newest first

Period Debt to equity Change
Sep 2026 0.0× —
Jun 2026 1.1× 98.04%
Mar 2026 0.5× (6.78%)
Dec 2025 0.6× 3.66%
43 more quarters

Against its own ten years

Low 0.5× High 2.7×
Ten-year median 1.3×
Current reading's percentile 8

Debt to equity against peers

Company Debt to equity
ALVO Alvotech compare −6.8×
PBH Prestige Consumer Healthcare Inc. 0.0×
BCRX BioCryst Pharmaceuticals, Inc. compare 0.0×
RGC Regencell Bioscience Holdings Limited compare 0.0×
AMLX Amylyx Pharmaceuticals, Inc. compare 0.0×
TRLV Trulieve Cannabis Corp. compare 0.0×
HCM HUTCHMED (China) Limited Sponsored ADR compare 0.1×
PRGO Perrigo Company plc compare 1.3×
XERS Xeris Biopharma Holdings, Inc. compare 3.9×
Drug Manufacturers Specialty & Generic industry median 0.0×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on PBH